Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-04-17

Clinical Trial Update: Comparison of Liposomal Doxorubicin Used Alone or in Combination With Bleomycin Plus Vincristine in the Treatment of Kaposi's Sarcoma in Patients With AIDS [Phase 2]

View source ↗

Summary

Phase 2 trial comparing liposomal doxorubicin alone versus in combination with bleomycin and vincristine for Kaposi's sarcoma in AIDS patients; the study has co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bleomycin (bleomycin)
  • Vincristine (vincristine)
  • liposomal doxorubicin (doxorubicin liposomal)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Sarcoma, Kaposi, HIV Infections | Phase 2 | Status: COMPLETED